Report Detail
Global Edaravone Injection Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
- RnM2776974 |
- 17 January, 2019 |
- Global |
- 104 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Edaravone, sold as under the brand names Radicava and Radicut, is an intravenous medication used to help with recovery following a stroke[1] and to treat amyotrophic lateral sclerosis (ALS).
Scope of the Report:
The worldwide market for Edaravone Injection is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Edaravone Injection in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Mitsubishi Tanabe Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
20ml
100ml
Market Segment by Applications, can be divided into
Hospital
Pharmacy
There are 15 Chapters to deeply display the global Edaravone Injection market.
Chapter 1, to describe Edaravone Injection Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Edaravone Injection, with sales, revenue, and price of Edaravone Injection, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Edaravone Injection, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Edaravone Injection market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Edaravone Injection sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents
1 Market Overview
- 1.1 Edaravone Injection Introduction
- 1.2 Market Analysis by Type
- 1.2.1 20ml
- 1.2.2 100ml
- 1.3 Market Analysis by Applications
- 1.3.1 Hospital
- 1.3.2 Pharmacy
- 1.4 Market Analysis by Regions
- 1.4.1 North America (United States, Canada and Mexico)
- 1.4.1.1 United States Market States and Outlook (2013-2023)
- 1.4.1.2 Canada Market States and Outlook (2013-2023)
- 1.4.1.3 Mexico Market States and Outlook (2013-2023)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy)
- 1.4.2.1 Germany Market States and Outlook (2013-2023)
- 1.4.2.2 France Market States and Outlook (2013-2023)
- 1.4.2.3 UK Market States and Outlook (2013-2023)
- 1.4.2.4 Russia Market States and Outlook (2013-2023)
- 1.4.2.5 Italy Market States and Outlook (2013-2023)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- 1.4.3.1 China Market States and Outlook (2013-2023)
- 1.4.3.2 Japan Market States and Outlook (2013-2023)
- 1.4.3.3 Korea Market States and Outlook (2013-2023)
- 1.4.3.4 India Market States and Outlook (2013-2023)
- 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
- 1.4.4 South America, Middle East and Africa
- 1.4.4.1 Brazil Market States and Outlook (2013-2023)
- 1.4.4.2 Egypt Market States and Outlook (2013-2023)
- 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
- 1.4.4.4 South Africa Market States and Outlook (2013-2023)
- 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
- 1.4.1 North America (United States, Canada and Mexico)
- 1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force
2 Manufacturers Profiles
- 2.1 Mitsubishi Tanabe Pharma
- 2.1.1 Business Overview
- 2.1.2 Edaravone Injection Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Mitsubishi Tanabe Pharma Edaravone Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Edaravone Injection Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
- 3.1 Global Edaravone Injection Sales and Market Share by Manufacturer (2016-2017)
- 3.2 Global Edaravone Injection Revenue and Market Share by Manufacturer (2016-2017)
- 3.3 Market Concentration Rate
- 3.3.1 Top 3 Edaravone Injection Manufacturer Market Share in 2017
- 3.3.2 Top 6 Edaravone Injection Manufacturer Market Share in 2017
- 3.4 Market Competition Trend
4 Global Edaravone Injection Market Analysis by Regions
- 4.1 Global Edaravone Injection Sales, Revenue and Market Share by Regions
- 4.1.1 Global Edaravone Injection Sales and Market Share by Regions (2013-2018)
- 4.1.2 Global Edaravone Injection Revenue and Market Share by Regions (2013-2018)
- 4.2 North America Edaravone Injection Sales and Growth Rate (2013-2018)
- 4.3 Europe Edaravone Injection Sales and Growth Rate (2013-2018)
- 4.4 Asia-Pacific Edaravone Injection Sales and Growth Rate (2013-2018)
- 4.5 South America Edaravone Injection Sales and Growth Rate (2013-2018)
- 4.6 Middle East and Africa Edaravone Injection Sales and Growth Rate (2013-2018)
5 North America Edaravone Injection by Countries
- 5.1 North America Edaravone Injection Sales, Revenue and Market Share by Countries
- 5.1.1 North America Edaravone Injection Sales and Market Share by Countries (2013-2018)
- 5.1.2 North America Edaravone Injection Revenue and Market Share by Countries (2013-2018)
- 5.2 United States Edaravone Injection Sales and Growth Rate (2013-2018)
- 5.3 Canada Edaravone Injection Sales and Growth Rate (2013-2018)
- 5.4 Mexico Edaravone Injection Sales and Growth Rate (2013-2018)
6 Europe Edaravone Injection by Countries
- 6.1 Europe Edaravone Injection Sales, Revenue and Market Share by Countries
- 6.1.1 Europe Edaravone Injection Sales and Market Share by Countries (2013-2018)
- 6.1.2 Europe Edaravone Injection Revenue and Market Share by Countries (2013-2018)
- 6.2 Germany Edaravone Injection Sales and Growth Rate (2013-2018)
- 6.3 UK Edaravone Injection Sales and Growth Rate (2013-2018)
- 6.4 France Edaravone Injection Sales and Growth Rate (2013-2018)
- 6.5 Russia Edaravone Injection Sales and Growth Rate (2013-2018)
- 6.6 Italy Edaravone Injection Sales and Growth Rate (2013-2018)
7 Asia-Pacific Edaravone Injection by Countries
- 7.1 Asia-Pacific Edaravone Injection Sales, Revenue and Market Share by Countries
- 7.1.1 Asia-Pacific Edaravone Injection Sales and Market Share by Countries (2013-2018)
- 7.1.2 Asia-Pacific Edaravone Injection Revenue and Market Share by Countries (2013-2018)
- 7.2 China Edaravone Injection Sales and Growth Rate (2013-2018)
- 7.3 Japan Edaravone Injection Sales and Growth Rate (2013-2018)
- 7.4 Korea Edaravone Injection Sales and Growth Rate (2013-2018)
- 7.5 India Edaravone Injection Sales and Growth Rate (2013-2018)
- 7.6 Southeast Asia Edaravone Injection Sales and Growth Rate (2013-2018)
8 South America Edaravone Injection by Countries
- 8.1 South America Edaravone Injection Sales, Revenue and Market Share by Countries
- 8.1.1 South America Edaravone Injection Sales and Market Share by Countries (2013-2018)
- 8.1.2 South America Edaravone Injection Revenue and Market Share by Countries (2013-2018)
- 8.2 Brazil Edaravone Injection Sales and Growth Rate (2013-2018)
- 8.3 Argentina Edaravone Injection Sales and Growth Rate (2013-2018)
- 8.4 Colombia Edaravone Injection Sales and Growth Rate (2013-2018)
9 Middle East and Africa Edaravone Injection by Countries
- 9.1 Middle East and Africa Edaravone Injection Sales, Revenue and Market Share by Countries
- 9.1.1 Middle East and Africa Edaravone Injection Sales and Market Share by Countries (2013-2018)
- 9.1.2 Middle East and Africa Edaravone Injection Revenue and Market Share by Countries (2013-2018)
- 9.2 Saudi Arabia Edaravone Injection Sales and Growth Rate (2013-2018)
- 9.3 UAE Edaravone Injection Sales and Growth Rate (2013-2018)
- 9.4 Egypt Edaravone Injection Sales and Growth Rate (2013-2018)
- 9.5 Nigeria Edaravone Injection Sales and Growth Rate (2013-2018)
- 9.6 South Africa Edaravone Injection Sales and Growth Rate (2013-2018)
10 Global Edaravone Injection Market Segment by Type
- 10.1 Global Edaravone Injection Sales, Revenue and Market Share by Type (2013-2018)
- 10.1.1 Global Edaravone Injection Sales and Market Share by Type (2013-2018)
- 10.1.2 Global Edaravone Injection Revenue and Market Share by Type (2013-2018)
- 10.2 20ml Sales Growth and Price
- 10.2.1 Global 20ml Sales Growth (2013-2018)
- 10.2.2 Global 20ml Price (2013-2018)
- 10.3 100ml Sales Growth and Price
- 10.3.1 Global 100ml Sales Growth (2013-2018)
- 10.3.2 Global 100ml Price (2013-2018)
11 Global Edaravone Injection Market Segment by Application
- 11.1 Global Edaravone Injection Sales Market Share by Application (2013-2018)
- 11.2 Hospital Sales Growth (2013-2018)
- 11.3 Pharmacy Sales Growth (2013-2018)
12 Edaravone Injection Market Forecast (2018-2023)
- 12.1 Global Edaravone Injection Sales, Revenue and Growth Rate (2018-2023)
- 12.2 Edaravone Injection Market Forecast by Regions (2018-2023)
- 12.2.1 North America Edaravone Injection Market Forecast (2018-2023)
- 12.2.2 Europe Edaravone Injection Market Forecast (2018-2023)
- 12.2.3 Asia-Pacific Edaravone Injection Market Forecast (2018-2023)
- 12.2.4 South America Edaravone Injection Market Forecast (2018-2023)
- 12.2.5 Middle East and Africa Edaravone Injection Market Forecast (2018-2023)
- 12.3 Edaravone Injection Market Forecast by Type (2018-2023)
- 12.3.1 Global Edaravone Injection Sales Forecast by Type (2018-2023)
- 12.3.2 Global Edaravone Injection Market Share Forecast by Type (2018-2023)
- 12.4 Edaravone Injection Market Forecast by Application (2018-2023)
- 12.4.1 Global Edaravone Injection Sales Forecast by Application (2018-2023)
- 12.4.2 Global Edaravone Injection Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
- 13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.1.3 Marketing Channel Future Trend
- 13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
- 15.1 Methodology
Summary:
Get latest Market Research Reports on Edaravone Injection . Industry analysis & Market Report on Edaravone Injection is a syndicated market report, published as Global Edaravone Injection Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Edaravone Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
